Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jan 27, 2024; 16(1): 1-11
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.1
Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage
Jorge Quarleri, M Victoria Delpino
Jorge Quarleri, M Victoria Delpino, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires 1121, Argentina
Author contributions: Quarleri J and Delpino MV contributed equally to this work; Quarleri J and Delpino MV have analyzed the data, written the manuscript, read and approved the final version.
Supported by Agencia Nacional de Promoción Científica y Tecnológica (PICTO-2021-COVID secuelas-00005 to JQ).
Conflict-of-interest statement: Jorge Quarleri and M Victoria Delpino are members of the CONICET Research Career Program. The authors disclose no financial conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jorge Quarleri, PhD, Adjunct Professor, Research Scientist, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155, Buenos Aires 1121, Argentina. quarleri@fmed.uba.ar
Received: October 26, 2023
Peer-review started: October 26, 2023
First decision: December 1, 2023
Revised: December 4, 2023
Accepted: December 28, 2023
Article in press: December 28, 2023
Published online: January 27, 2024
Processing time: 88 Days and 12.9 Hours
Core Tip

Core Tip: The hepatotropism of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a growing concern amid the coronavirus disease 2019 (COVID-19) pandemic. Despite its respiratory focus, the virus significantly affects various organs, notably the liver, leading to complications like inflammation, abnormal function tests, and, in severe cases, organ damage. This complex involvement worsens disease outcomes. Understanding the virus's interplay with the liver, mediated by the Angiotensin-converting enzyme-2 receptor, is crucial for tailored treatments. The liver's pivotal role in the immune response emphasizes the need to comprehend SARS-CoV-2 hepatotropism. Ongoing research is vital for uncovering mechanisms, clinical implications, and effective strategies in managing COVID-19 patients with liver involvement.